|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.28 USD | +3.80% |
|
+28.40% | -28.47% |
Palisade Bio, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 12.3 million compared to USD 14.26 million a year ago. Basic loss per share from continuing operations was USD 1.8 compared to USD 16.53 a year ago.
Diluted loss per share from continuing operations was USD 1.8 compared to USD 16.53 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -28.47% | 5.15M | |
| +2.17% | 42.75B | |
| +47.64% | 41.61B | |
| +12.11% | 41.34B | |
| -12.36% | 26.59B | |
| +8.10% | 25.49B | |
| -22.99% | 18.12B | |
| +30.64% | 12.24B | |
| -1.46% | 11.76B | |
| +8.47% | 11B |
PALISADE BIO, INC. 
